Alan is an entrepreneurial life sciences executive and board member who has launched three multi-billion dollar biotechnology companies, raised over $1.75 billion in private and public capital, consummated five IPOs, and executed numerous life sciences technology transactions. His senior leadership operating experience in development-stage biotechnology companies includes finance, business development, corporate strategy, operations & administration, accounting, human resources, legal, information technology, facilities, corporate communications, and investor relations.